2019) Evaluating natural killer cell cytotoxicity against solid tumors using a microfluidic model, OncoImmunology, 8:3, 1553477, ABSTRACT Immunotherapies against solid tumors face additional challenges compared with hematological cancers. In solid tumors, immune cells and antibodies need to extravasate from vasculature, find the tumor, and migrate through a dense mass of cells. These multiple steps pose significant obstacles for solid tumor immunotherapy and their study has remained difficult using classic in vitro models based on Petri dishes. In this work, a microfluidic model has been developed to study natural killer cell response. The model includes a 3D breast cancer spheroid in a 3D extracellular matrix, and two flanking lumens lined with endothelial cells, replicating key structures and components during the immune response. Natural Killer cells and antibodies targeting the tumor cells were either embedded in the matrix or perfused through the lateral blood vessels. Antibodies that were perfused through the lateral lumens extravasated out of the blood vessels and rapidly diffused through the matrix. However, tumor cell-cell junctions hindered antibody penetration within the spheroid. On the other hand, natural killer cells were able to detect the presence of the tumor spheroid several hundreds of microns away and penetrate the spheroid faster than the antibodies. Once inside the spheroid, natural killer cells were able to destroy tumor cells at the spheroid periphery and, importantly, also at the innermost layers. Finally, the combination of antibody-cytokine conjugates and natural killer cells led to an enhanced cytotoxicity located mostly at the spheroid periphery. Overall, these results demonstrate the utility of the model for informing immunotherapy of solid tumors. ARTICLE HISTORY
Introduction: Solid tumors develop a complex microenvironment; that enables immune surveillance escape. In solid tumors, cancer cells form a dense mass where antibody and immune cell penetration is significantly hindered. Additionally, tumor cell metabolism leads to hypoxia, nutrient starvation and acidic pH; that dampens immune response. Therefore, to translate the success of immunotherapies in hematological cancers to solid tumors; there is need for new in vitro models that recapitulate this complex tumor microenvironment (TME). In this context, microfluidics offers an opportunity to generate sophisticated in vitro systems, combining multiple cell types and capturing in vivo spatial organization. Here, we present a microfluidic model that mimics the TME of solid tumors and apply it to study adoptive immunotherapies and therapeutic antibodies. Materials and Methods: In our model, a spheroid of MCF7 breast cancer cells was embedded in a 3D collagen I matrix. Multiple luminal structures were generated through the matrix adjacent to the spheroid and lined with endothelial cells (e.g., HUVECs, IPSC-EC) to form blood vessels. Activated immune cells (e.g., NK-92 cells) and/or therapeutic antibodies (e.g., IL-2 conjugated anti-EpCAM) were perfused through these blood vessels. Antibody diffusion, cell migration and cytotoxicity were subsequently measured by fluorescence and confocal microscopy. Results and Discussion: A small percentage of NK cells extravasated from the blood vessel into the matrix. Once within the extracellular matrix, NK cells exhibited rapid migration; however, we did not observe a directional response towards the tumor spheroid. In fact, the NK cells that reached the spheroid followed a random, tortuous path. Taken together, these initial results point out that immune extravasation and “homing” (i.e., the capacity to track and migrate towards tumor cells) could be engineered to improve treatment efficacy. After several days in culture, the presence of NK cells induced significant cytotoxicity in the MCF7 spheroid. NK cell-mediated cytotoxicity occurred at the surface of the tumor spheroid; whereas tumor cells in the core remained unaffected. Different therapeutic antibody formulations were perfused through the adjacent lumen to enhance NK-mediated cytotoxicity. Fluorescently-labelled antibodies diffused through the blood vessel, reaching and coating the surface of the spheroid in a few hours. However, penetration of the core was dramatically slower; after 3 days, only the most outer cell layers of the spheroid were stained. The antibody remained attached to the tumor cell membrane for multiple days, showing no signs of internalization. Therefore, this model could be used to study the efficacy of antibody-dependent therapy, in particular, short and repeated cycles of antibody/immune cell injection. Conclusion: The TME can dramatically limit the immune response against solid tumors. The presented microfluidic model was used to study NK cell extravasation, migration and tumor cytotoxicity in 3D. This microfluidic model provides a TME that more closely mimics in vivo conditions compared with standard assays. Therapeutic antibodies were also evaluated; demonstrating this model can be applied to find the optimal protocol for adoptive immunotherapies combined with therapeutic antibodies. Citation Format: Jose Maria Ayuso, Regan Truttschel, Max M. Gong, Mouhita Humayun, Amani Gillette, Manish Patankar, Melissa C. Skala, David J. Beebe. Microfluidics to study solid tumor-NK cell interactions: From migration and cytotoxicity to therapeutic antibodies [abstract]. In: Proceedings of the AACR Special Conference on Tumor Immunology and Immunotherapy; 2017 Oct 1-4; Boston, MA. Philadelphia (PA): AACR; Cancer Immunol Res 2018;6(9 Suppl):Abstract nr B32.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.